USPTO serial 79175570
INXITU
Reviewed by CopyMark Law Group
Reg. 5038470Status 404
- Filing date
- Status date
- Registration date
- Sep 13, 2016
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INXITU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leslie Bertagnolli
Leslie Bertagnolli Baker & McKenzie LLP300 East Randolph Street, Suite 5000Chicago, IL 60601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of diabetes; pharmaceutical preparations for the treatment and prevention of cardiovascular diseases; pharmaceutical preparations for the treatment and prevention of diseases of the central nervous system; pharmaceutical preparations for the prevention and treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer; sanitary products for medical purposes, namely sanitary towels, sanitary napkins, sanitary sterilizing preparations; implants for pharmaceuticals use, namely implants comprising living tissue, biological implants or medical implants; implantable medicines for the prevention and treatment of diabetes, cardiovascular diseases, diseases of the central nervous system, metabolic disorders, cancer | SECTION 71 - CANCELLED | — |
| 010 | Implantable drug delivery systems for the treatment and prevention of diabetes; implantable drug delivery systems for the treatment and prevention of cardiovascular diseases; implantable drug delivery systems for the treatment and prevention of diseases of the central nervous system; implantable drug delivery systems for the prevention and treatment of metabolic disorders; implantable drug delivery systems for the treatment of cancer; medical apparatus and instruments for use in surgery or use in application of surgical implants comprised primarily of artificial material; Medical apparatus, namely, applicators for medicines in the nature of patches, namely, drug delivery patches sold without medication and transdermal drug delivery patches sold without medication, osmotic pumps for administering medicine; medical implants made of artificial material for delivering medicine; artificial surgical implants, namely, surgical implants comprising artificial material; holders for medical use, namely, holders specially adapted for placement of medical and surgical applicators; Medical apparatus, namely, applicators for pharmaceutical preparations, namely, subcutaneous applicators for administering medicine; pumps for medical use, namely, osmotic pumps and infusion pumps for administering pharmaceutical products contained in receptacles; medical devices, namely, infusion pumps for administering medicines; injection devices for pharmaceutical products; surgical apparatus and instruments for use in cardiovascular surgery, central nervous system surgery, oncology surgery, orthopedic surgery or surgery for application of implants; cases fitted for medical instruments; suture materials; scalpels; knives for surgical purposes; surgical knives; scissors for surgery; knives for surgical use; cases fitted for use by doctors; containers especially made for medical waste; receptacles for applying medicines, namely, medical fluid injectors and infusers | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Feb 12, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 8, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jan 8, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 7, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 18, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 18, 2023 | INPC | INVALIDATION PROCESSED | — |
| Nov 24, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 24, 2023 | C71T | CANCELLED SECTION 71 | — |
| Sep 13, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 10, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 15, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 15, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 13, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 13, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 2, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 28, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 28, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 8, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 8, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 8, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 23, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 19, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 19, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 28, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 27, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 27, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 11, 2015 | RFNP | REFUSAL PROCESSED BY IB | — |
| Nov 20, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 20, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 18, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 17, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 12, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 12, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 9, 2015 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 6, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |